Patients with AKI requiring RRT on #ECMO, 33% had CKD at 1 year post-survival, with increased mortality. #pics #PostICUclinic @ALBellinghausen @DrBobOwens https://t.co/WbehBr6smc
VV-ECMO and AKI: a fatal combination?Figure 1 panel du haut https://t.co/P3CoHLT2EQ @NutthaLumlertgul #Mortality #Outcomes #RenalReplacementTherapy #AIC #FICS #SRLF https://t.co/XqNViEhEyd
RT @YukiKotani5: ✅1-year #mortality & kidney outcomes in 300 pts on #VVECMO 🇬🇧Single-center retrospective study ▶️59% received KRT and th…
RT @YukiKotani5: ✅1-year #mortality & kidney outcomes in 300 pts on #VVECMO 🇬🇧Single-center retrospective study ▶️59% received KRT and th…
RT @YukiKotani5: ✅1-year #mortality & kidney outcomes in 300 pts on #VVECMO 🇬🇧Single-center retrospective study ▶️59% received KRT and th…
✅1-year #mortality & kidney outcomes in 300 pts on #VVECMO 🇬🇧Single-center retrospective study ▶️59% received KRT and their 1-year mortality was 32% ▶️Among survivors who received KRT in the #ICU and had available Cr at 1 year, 33% had #CKD 🔗https:
La plus grande étude ECMO-VV + IRA évaluant les résultats rénaux à court / long terme : (i) Recours a l’EER ; (ii) dependance % dialyse; (iii) mortalité long terme; (iv) suivi Nephro a distance; (v) IRC tardive... https://t.co/bd0mYrlCtj
RT @torisugari_anes: https://t.co/lyHud4LXQk VV-ECMO患者で、AKIの有無で予後が変わるかを調べた後ろ向き研究 結果は、AKIでRRTを受けた患者の1年死亡率は32%、非AKI患者では21.4だった。RRTを受けた患者は受けなか…
https://t.co/lyHud4LXQk VV-ECMO患者で、AKIの有無で予後が変わるかを調べた後ろ向き研究 結果は、AKIでRRTを受けた患者の1年死亡率は32%、非AKI患者では21.4だった。RRTを受けた患者は受けなかった患者よりも死亡率が高かった(aHR:1.80[1.06-3.06]) #当麻_腎・電解質